Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (361)	12/9/1997 8:24:00 PM
From: Cymeed	Read Replies (2) \| Respond to of 887

Dave and Doc, I believe your two are right in that Institutional investors will be the key. My previous kidding about Tom was purely joke. I probably should say sorry to Tom, who introduced me to Depo and answered many of my tough questions. Thanks for all of your valuable help, Tom, and I do apologize if my joke made you feel uncomfortable. The DepoCyt approval will not be very hot, IMO. The reason is that, the craziness went away one year ago when the stock hit almost $30 upon that news. A lot of institutional holders probably got burnt and cold on this one. I bet they are taking a more cautious step toward the full FDA approval this time. In other words, those burnt instituational investors may not take a major holding until they see some true results, I mean either full FDA approval or revenue/earning growth. Longer term, this baby got a good chance, though. JMHO.